FDA Import Refusal J37-0009050-2/71/1C — Legasi Pharmaceuticals Switzerland GmbH
The FDA refused shipment J37-0009050-2/71/1C from Legasi Pharmaceuticals Switzerland GmbH (Switzerland) on May 23, 2017. The refused product falls under Drugs and Biologics — EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.. Cited charges: 118,16,3280,472 This firm has 1 other import refusal on record.
Refusal details
- Date
- May 23, 2017
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 66YDJ99 EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
- Charges
- 118,16,3280,472